The global branched stent grafts market expanded at
a CAGR of 8.0%. between 2021 to 2028. The market has been ever-growing for the
past few decades, the reason being the increasing number of coronary heart
diseases. Further, the rising geriatric population will also drive the market
over the forecast period.
ResearchMoz report delivers an in-depth analysis of the global stent
grafts interface marketplace, including its size, key drivers for growth, major
opportunities and challenges it faces along with the regional segments that
will experience significant expansion over time.
Polymer-Based
Technology to Drive the Branched Stent Grafts Market
Recently, polymer-based technologies have been recommended as an
alternative to fix abdominal aortic aneurysms (AAA). There are two categories
under this technology- one is Endovascular Aneurysm Sealing (EVAS), which uses
polymer filled end bags and Nellix Stent Grafts. The second, EVAR, uses a thin
neoprene-based neck sealing device that’s also called the Ovation stent graft.
EVAS was not successful despite being in use for some time now but EVAR has
established itself as safe and effective; leading to the expansion of the
global branched stents market.
Growing Vascular
Surgeries Boost Demand
The growing number of vascular surgeries are driving the global branched
stent grafts market and will continue during the forecast period. This is
primarily due to the growing geriatric population across the globe and growing
cases of coronary heart diseases.
However, the poor durability of metallic grafts will impede the growth
during the forecast period.
Nonetheless, the rising demand for biocompatible stents will allow the
market to grow exponentially in the coming years.
Analysts Views
The demand for biocompatible stent grafts will go up as it has good
durability.
Advancements in medical technology are helping with diagnostic and
therapeutic treatments on various diseases; this leads to a lowering of
mortality rates. This will lead to the growth of this market during the
forecast period.
The growing demand for minimally invasive procedures will drive the
global branched stent market to expand in the coming years.
Regional Overview
Regionally, the North America Branched Stent Grafts market is
anticipated to hold the largest share in this market during the forecast
period. The growth can be ascribed to the strong presence of major players in
the region, as well as technologically advanced health infrastructure. The
increasing prevalence of coronary artery diseases and the rising number of
geriatric populations in North America will also be driving the growth of this
market. Europe is another promising region for these products, despite
tough competition from Asia-Pacific.
The Asia Pacific seems like a favorable location, the reason being an
increased incidence rate of coronary artery diseases in the region due to
lifestyle diseases; medical tourism and higher spending on healthcare will also
drive the global branched stent market during the forecast years.
The players in the global branched stent-grafts market include-
- Abbott
- Cook
Medical
- Eucatech
AG
- Merit
Medical Systems
- Endocor
GmbH
- Boston
Scientific Corp.
- Terumo
Corp.
- Medtronic
- Biotronik
- Alvimedica
- Cardinal
Health (Cordis)
Download FREE
Report Sample (PDF with Insights, Charts, Tables, Figures) at: https://www.researchmoz.us/request-free-sample/?reportid=1453
No comments:
Post a Comment